Defunct Company
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
221
NCT00086216
Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 31, 2004
Completion: Nov 30, 2007
NCT00214838
An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer
Start: Mar 31, 2005
Completion: Mar 31, 2007
NCT00430014
Study of Atiprimod Treatment for Patients With Advanced Cancer
Phase: Phase 1
Role: Collaborator
Completion: Feb 29, 2012
NCT00271063
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Start: Oct 31, 2005
Completion: Apr 30, 2008
NCT00388063
Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
Phase: Phase 2
Start: Oct 31, 2006
Completion: Sep 30, 2007
NCT00430443
Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML
Start: Feb 28, 2007
Completion: Jan 31, 2009
NCT00663429
Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma
Start: Nov 30, 2007
Completion: Mar 31, 2010